Gene Therapy For Neurodegenerative Diseases Market Size, Share, Opportunities, And Trends Type Of Neurogenerative Disease (Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis (Als), Multiple System Atrophy (Msa), Spinocerebellar Ataxias, Others), By Therapeutic Approach (Gene Replacement Therapy, Gene Silencing Therapy (Rnai), Gene Editing Therapy (Crispr-Cas9), Neurotrophic Factor Delivery, Enzyme Replacement Therapy), By Vector Type (Adeno-Associated Virus (Aav), Lentivirus, Retrovirus, Non-Viral Vectors), By End-User (Hospitals And Clinics, Research Institutions, Biotechnology Companies, Pharmaceutical Companies), And By Geography - Forecasts From 2023 To 2028